Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonja Schrepfer

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Annals of the American Thoracic Society|September 26, 2017
Opportunities for Lung Repair and Regeneration: An OverviewSonja Schrepfer
Cell Stem Cell|April 4, 2025
Progress and challenges in developing allogeneic cell therapiesTobias Deuse, Sonja Schrepfer
Transplantation|August 27, 2015
Distal Airway Stem Cells are Essential for Lung RegenerationTobias Deuse, Sonja Schrepfer
Cell Reports. Medicine|July 2, 2026
Transplantation tolerance versus immune evasion: Mechanistic divergences and therapeutic frontiers for islet cell replacementTobias Deuse, Sonja Schrepfer
Transplantation|April 16, 2004
The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependentTobias Deuse, Sonja Schrepfer, Hermann Reichenspurner
Microsurgery|July 2, 2003
New technique for chest opening in mice: U-sternotomySonja Schrepfer, Tobias Deuse, Hermann Reichenspurner
Transplantation|January 2, 2004
Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation modelTobias Deuse, Sonja Schrepfer, Hermann Reichenspurner
Annals of Translational Medicine|November 10, 2016
miR-126: a potential new key player in hypoxia and reperfusion?Sabina P W Guenther, Sonja Schrepfer
The New England Journal of Medicine|December 17, 2025
Allogeneic Beta Cells with No Immunosuppression. ReplyPer-Ola Carlsson, Tobias Deuse, Sonja Schrepfer
Transplant International : Official Journal of the European Society for Organ Transplantation|February 5, 2005
FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survivalSonja Schrepfer, Tobias Deuse, Hansjörg Schäfer, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Annals of the American Thoracic Society|September 26, 2017
Opportunities for Lung Repair and Regeneration: An OverviewSonja Schrepfer
Cell Stem Cell|April 4, 2025
Progress and challenges in developing allogeneic cell therapiesTobias Deuse, Sonja Schrepfer
Transplantation|August 27, 2015
Distal Airway Stem Cells are Essential for Lung RegenerationTobias Deuse, Sonja Schrepfer
Cell Reports. Medicine|July 2, 2026
Transplantation tolerance versus immune evasion: Mechanistic divergences and therapeutic frontiers for islet cell replacementTobias Deuse, Sonja Schrepfer
Transplantation|April 16, 2004
The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependentTobias Deuse, Sonja Schrepfer, Hermann Reichenspurner
Microsurgery|July 2, 2003
New technique for chest opening in mice: U-sternotomySonja Schrepfer, Tobias Deuse, Hermann Reichenspurner
Transplantation|January 2, 2004
Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation modelTobias Deuse, Sonja Schrepfer, Hermann Reichenspurner
Annals of Translational Medicine|November 10, 2016
miR-126: a potential new key player in hypoxia and reperfusion?Sabina P W Guenther, Sonja Schrepfer
The New England Journal of Medicine|December 17, 2025
Allogeneic Beta Cells with No Immunosuppression. ReplyPer-Ola Carlsson, Tobias Deuse, Sonja Schrepfer
Transplant International : Official Journal of the European Society for Organ Transplantation|February 5, 2005
FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survivalSonja Schrepfer, Tobias Deuse, Hansjörg Schäfer, et al.
Pageof 11